Nectar Lifesciences Limited (NECLIFE.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.87B |
| Enterprise Value | 747.57M |
| P/E Ratio | -0.91 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 27.07 |
| Price/Book Ratio | 0.35 |
| Enterprise/Revenue | 27.07 |
| Enterprise/EBITDA | 24.07 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -32.93 |
| Operating Margin | -11.72 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | -0.38 |
Income Statement
| Revenue | 20.11M |
| Revenue/Share | 0.38 |
| Gross Profit | -590.34M |
| EBITDA | -289.51M |
| Net Income | -2.93B |
| Diluted EPS | -14.57 |
Balance Sheet
| Total Cash | 1.25B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 29.97 |
Price History
| 52-Week Change | -28.53 |
| 52-Week High | 22.4 |
| 52-Week Low | 9.3 |
| Moving Average 50 Days | 10.81 |
| Moving Average 200 Days | 11.46 |
Statistics
| Average Volume | 209,836 |
| Shares Outstanding | 194.26M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 10:1 |
| Last Split Date | November 12, 2008 |
AD
